Skip to main content
. 2017 Dec 8;16:235. doi: 10.1186/s12944-017-0624-1

Table 1.

Clinical characteristics of AML patients and a reference group

AML Patients (n = 49)
FAB
Subtype
Number of patients Age Sex
F/M
AML M0 2 53 ± 0 2/0
AML M1 6 57.5 ± 19.25 5/1
AML M2 15 58.8 ± 15.53 8/7
AML M4 8 70.25 ± 12.89 5/3
AML M5 4 63 ± 20.92 2/2
AML M5b 5 62.8 ± 9.4 2/3
AML/MDS 9 59.44 ± 11.51 4/5
All patients 49 61.14 ± 15.07 28/21
Reference group (n = 51)
Control group 51 58.68 ± 19.77 24/27